Key Points: Addition of hemodiafiltration has a relatively small impact on reducing either predialysis or time-averaged serum -2-microglobulin levels. Residual kidney function has a major impact on the predialysis and time-averaged serum -2-microglobulin levels.
Background: A kinetic model for -2-microglobulin removal and generation was used to explore the impact of adding hemodiafiltration on predialysis and time-averaged serum values.
Methods: The model was tested on data from the HEMO study and on a sample of patients undergoing high-flux hemodialysis. The impact of hemodiafiltration on -2-microglobulin levels was evaluated by modeling four randomized studies of hemodiafiltration versus hemodialysis. The impact of residual kidney function on -2-microglobulin was tested by comparing results of previously reported measured data with model predictions.
Results: In the low-flux and high-flux arms of the HEMO study, measured median -2-microglobulin reduction ratios could be matched by dialyzer clearances of 5.9 and 29 ml/min, respectively. Median predialysis serum -2-microglobulin levels were matched if generation rates of -2-microglobulin were set to approximately 235 mg/d. In another group of patients treated with dialyzers with increased -2-microglobulin clearances, measured cross-dialyzer clearances (57±28 ml/min) were used as inputs. In these studies, the kinetic model estimates of intradialysis and early postdialysis serum -2-microglobulin levels were similar to median measured values. The model was able to estimate the changes in predialysis serum -2-microglobulin in each of four published randomized comparisons of hemodiafiltration with hemodialysis, although the model predicted a greater decrease in predialysis serum -2-microglobulin with hemodiafiltration than was reported in two of the studies. The predicted impact of residual kidney clearance on predialysis serum -2-microglobulin concentrations was similar to that reported in one published observational study. Modeling predicted that postdilution hemodiafiltration using 25 L/4 hours replacement fluid would lower serum time-averaged concentration of -2-microglobulin by about 18.2%, similar to the effect of 1.50 ml/min residual kidney GFR.
Conclusions: A two-pool kinetic model of -2-microglobulin yielded values of reduction ratio and predialysis serum concentration that were consistent with measured values with various hemodiafiltration and hemodialysis treatment regimens.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254023 | PMC |
http://dx.doi.org/10.2215/CJN.0000000000000461 | DOI Listing |
Neuroreport
January 2025
Department of Neurology, the Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou Province, China.
J Clin Lab Anal
December 2024
Servicio de Nefrologia, Hospital Universitario de Badajoz, Universidad de Extremadura, Badajoz, Spain.
Aims: Serum creatinine and albuminuria are the core of most CKD prediction and progression risk models. Several biomarkers have been introduced to improve these results such as beta-2-microglobulin (B2M) and cystatin C (CysC). Nevertheless, few clinical comparisons of these biomarkers are available.
View Article and Find Full Text PDFCPT Pharmacometrics Syst Pharmacol
December 2024
INSERM, IAME, Université Paris Cité, Paris, France.
Medicina (Kaunas)
November 2024
Department of Medical Oncology, Faculty of Medicine, Çukurova University, 01250 Adana, Turkey.
: One of the most critical problems regarding sarcopenia is the difficulty of the diagnosis process. This study aimed to determine the prevalence and investigate the role of serum beta-2 microglobulin level as a biomarker for diagnosing sarcopenia. : This nested case-control study was conducted between 2023 and 2024 on 251 older adults.
View Article and Find Full Text PDFPeerJ
November 2024
Department of Laboratory Medicine, Hangzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Background: Plasma cell dyscrasias encompass a diverse set of disorders, where early and precise diagnosis is essential for optimizing patient outcomes. Despite advancements, current diagnostic methodologies remain underutilized in applying artificial intelligence (AI) to routine laboratory data. This study seeks to construct an AI-driven model leveraging standard laboratory parameters to enhance diagnostic accuracy and classification efficiency in plasma cell dyscrasias.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!